Accelerating Preclinical Discovery with Organoids
- Human-relevant models you can trust – physiologically relevant organoids with consistent quality and validation
- Built for real programs, not just publications – scalable, reproducible, and ready for drug discovery workflows
- Experts who meet you where you are – from first experiments to scale-up, with real scientific partnership
Ready to Connect with Our Scientists?
Why Scientists Choose iXCells
We continuously deliver high-fidelity iPSC models and now support organoids that accelerate preclinical drug discovery and improve translational research outcomes. By integrating Rosebud Biosciences’ advanced organoid expertise with our scalable iPSC platform, we provide complex, reproducible 3D systems that replicate tissue-level biology and patient-specific diversity.
Our end-to-end workflows support disease modeling, drug safety testing, multi-omics profiling, and mechanism-of-action studies, enabling researchers to generate predictive, human-relevant data that informs critical development decisions and reduces late-stage attrition
Advanced Human-Relevant Model
Integrating organoid expertise with iXCells’ scalable iPSC platform gives access to complex 3D systems that closely mimic human tissue biology
End-to-End Workflow
From iPSC generation to organoid characterization, our integrated platform provides a reproducible, modular workflow for disease modeling, drug safety, and mechanism-of-action studies
Translational Impact
Our combined systems are designed to capture patient-specific biology, enabling more predictive preclinical studies and accelerating translational research in areas like rare diseases
Tailored and Scalable Solutions
Whether you need high-throughput screening or detailed multi-omics profiling, our platform offers scalable, customizable solutions tailored to your research needs